Screener
Haemonetics HAE Finite Lived Intangible Assets - Gross
Finite Lived Intangible Assets - Gross at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| June 27, 2026 | Gross Carrying Amount / (Dollars in Thousands) | Accumulated Amortization / (Dollars in Thousands) | Net Carrying Amount / (Dollars in Thousands) | Weighted Average Remaining Life (Years) |
|---|---|---|---|---|
| Customer contracts and related relationships | 129,601 | 77,475 | 52,126 | 11.1 |
| Capitalized software | 97,636 | 83,741 | 13,895 | 3.1 |
| Patents and other | 7,422 | 4,763 | 2,659 | 5.3 |
| Trade names | 14,608 | 7,428 | 7,180 | 10.2 |
| Total | $803,296 | $374,828 | $428,468 | |
| Non-amortizable: | ||||
| In-process software development | $6,044 | |||
| Total | $6,044 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's finite lived intangible assets - gross?
- Haemonetics (HAE) reported finite lived intangible assets - gross of $803.3M in Q2 2026.
- How has Haemonetics's finite lived intangible assets - gross changed year-over-year?
- Haemonetics's finite lived intangible assets - gross increased by 3.1% year-over-year, from $779.51M to $803.3M.
- What is the long-term trend for Haemonetics's finite lived intangible assets - gross?
- Over 3 years (2023 to 2026), Haemonetics's finite lived intangible assets - gross has grown at a 6.2% compound annual growth rate (CAGR), from $672.72M to $805.52M.
- What does finite lived intangible assets - gross mean?
- This metric tracks the total historical cost of intangible assets that have a defined useful life, such as patents, software licenses, or customer relationships. It excludes assets with indefinite lives like certain trademarks or goodwill. It is a key indicator of the company's investment in intellectual property and intangible competitive advantages.
Ask your AI about Haemonetics's finite lived intangible assets - gross.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude